{
    "2018-01-19": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Will Abbott’s 4Q17 Sales Results Exceed Analysts’ Expectations?",
                "features": {
                    "keywords": [
                        "Abbott",
                        "4Q17",
                        "Sales",
                        "Exceed",
                        "Analysts’ Expectations"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Will Varian Medical Systems’ Sales Decline Again in 1Q18?",
                "features": {
                    "keywords": [
                        "Varian",
                        "Medical",
                        "Systems",
                        "Sales",
                        "Decline",
                        "1Q18"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Wall Street Is Increasingly Bullish on ABT ahead of 4Q17 Results",
                "features": {
                    "keywords": [
                        "Wall Street",
                        "Bullish",
                        "ABT",
                        "4Q17",
                        "Results"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Can Diagnostics Business Drive Abbott's (ABT) Q4 Earnings?",
                "features": {
                    "keywords": [
                        "Diagnostics",
                        "Business",
                        "Drive",
                        "Abbott",
                        "ABT",
                        "Q4",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Merck & Co.’s Human Vaccines Business in 3Q17",
                "features": {
                    "keywords": [
                        "Merck",
                        "&",
                        "Co.",
                        "Human",
                        "Vaccines",
                        "Business",
                        "3Q17"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Analysts’ Recommendations for Amgen in January 2018",
                "features": {
                    "keywords": [
                        "Analysts’",
                        "Recommendations",
                        "Amgen",
                        "January",
                        "2018"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Can Diagnostics Business Drive Abbott's (ABT) Q4 Earnings?",
                "features": {
                    "keywords": [
                        "Diagnostics",
                        "Business",
                        "Drive",
                        "Abbott",
                        "ABT",
                        "Q4",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "See what the IHS Markit Score report has to say about Abbott Laboratories.",
                "features": {
                    "keywords": [
                        "IHS",
                        "Markit",
                        "Score",
                        "report",
                        "Abbott",
                        "Laboratories"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}